Global Artificial Intelligence (AI) in Biotechnology Market Size Study & Forecast, by Offering, Applications, Usage and Regional Forecasts 2025-2035

Description

The Global Artificial Intelligence (AI) in Biotechnology Market is valued at approximately USD 3.23 billion in 2024 and is expected to expand at a robust CAGR of over 19.10% during the forecast period 2025-2035. As the confluence of biotechnology and artificial intelligence gains rapid traction, AI is increasingly being deployed to unravel the complexities of biological data, accelerate drug discovery, and optimize biotechnological processes. With its powerful capability to detect patterns, predict outcomes, and automate research-intensive tasks, AI is being embraced across biotech verticals-from genomics and pharmaceutical development to agricultural biotechnology and precision diagnostics. This explosive growth trajectory is being propelled by the expanding need for efficient data analytics, cost-effective innovation in therapeutics, and the rise of personalized medicine. Additionally, the growing availability of structured and unstructured biomedical data sets, coupled with advancements in machine learning algorithms, has set the stage for transformative shifts in biotech research and development.

One of the primary catalysts underpinning this market surge is the unprecedented adoption of AI in drug target identification and screening. By employing deep learning and predictive modeling, researchers are now capable of narrowing down potential therapeutic targets in record time. According to industry insights, global biotech companies are rapidly integrating AI tools into their pipelines, significantly curbing both the costs and timelines of clinical trials. Furthermore, AI-driven platforms are playing a pivotal role in image analysis for medical diagnostics and cellular research. Governments and private enterprises are substantially investing in AI infrastructure to bolster national biotech initiatives, further fueling market demand. However, the landscape is not without challenges-concerns over data privacy, high implementation costs, and the need for domain-specific AI expertise remain critical constraints to broader adoption.

Regionally, North America is expected to dominate the AI in Biotechnology market by 2025, backed by its mature healthcare infrastructure, a strong presence of major biotech firms, and ongoing research funding. The U.S., in particular, has emerged as a breeding ground for AI-biotech collaborations, with leading pharmaceutical companies forging partnerships with AI startups. Meanwhile, Asia Pacific is anticipated to be the fastest-growing region over the forecast period. Countries such as China and India are intensifying their focus on biotech innovation, driven by a rising disease burden, supportive government regulations, and a surge in AI R&D investments. Europe is also making significant strides, with AI integration in life sciences research being spearheaded by Germany, the UK, and France. These regions are progressively building digital ecosystems conducive to the convergence of AI and biotechnology.

Major market player included in this report are:

Halliburton Company
Schlumberger Limited.
BASF SE
Baker Hughes Company
Impact Fluid Solutions
Chevron Phillips Chemical Company
M&D Industries Of Louisiana, Inc.
Aubin Group
Trican Well Service Ltd.
Croda International Plc.
IBM Corporation
Google DeepMind
NVIDIA Corporation
Intel Corporation
Biogen Inc.

Global Artificial Intelligence (AI) in Biotechnology Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Offering:

Software
Hardware
Services

By Applications:

Drug Target Identification
Drug Screening
Image Screening
Predictive Modeling

By Usage:

Agriculture Biotechnology
Medical Biotechnology
Animal Biotechnology
Industrial Biotechnology

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global AI in Biotechnology Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top-Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global AI in Biotechnology Market Forces Analysis

3.1. Market Forces Shaping The Global AI in Biotechnology Market (2024-2035)
3.2. Drivers
- 3.2.1. Rapid adoption of AI-driven analytics in drug discovery
- 3.2.2. Growing availability of biomedical big data sets
3.3. Restraints
- 3.3.1. Data privacy and security concerns
- 3.3.2. High implementation and integration costs
3.4. Opportunities
- 3.4.1. Expansion of precision medicine and personalized therapeutics
- 3.4.2. Strategic collaborations between AI and biotech firms

Chapter 4. Global AI in Biotechnology Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's Five Forces Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global AI in Biotechnology Market Size & Forecasts by Offering 2025-2035

5.1. Market Overview
5.2. Software
- 5.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.2.2. Market size analysis, by region, 2025-2035
5.3. Hardware
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Services
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global AI in Biotechnology Market Size & Forecasts by Applications 2025-2035

6.1. Market Overview
6.2. Drug Target Identification
- 6.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.2.2. Market size analysis, by region, 2025-2035
6.3. Drug Screening
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Image Screening
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Predictive Modeling
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035

Chapter 7. Global AI in Biotechnology Market Size & Forecasts by Usage 2025-2035

7.1. Market Overview
7.2. Agriculture Biotechnology
- 7.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.2.2. Market size analysis, by region, 2025-2035
7.3. Medical Biotechnology
- 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.3.2. Market size analysis, by region, 2025-2035
7.4. Animal Biotechnology
- 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.4.2. Market size analysis, by region, 2025-2035
7.5. Industrial Biotechnology
- 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.5.2. Market size analysis, by region, 2025-2035

Chapter 8. Global AI in Biotechnology Market Size & Forecasts by Region 2025-2035

8.1. AI in Biotechnology Market, Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America AI in Biotechnology Market
- 8.3.1. U.S. AI in Biotechnology Market
  - 8.3.1.1. Offering breakdown size & forecasts, 2025-2035
  - 8.3.1.2. Application breakdown size & forecasts, 2025-2035
- 8.3.2. Canada AI in Biotechnology Market
  - 8.3.2.1. Offering breakdown size & forecasts, 2025-2035
  - 8.3.2.2. Application breakdown size & forecasts, 2025-2035
8.4. Europe AI in Biotechnology Market
- 8.4.1. UK AI in Biotechnology Market
  - 8.4.1.1. Offering breakdown size & forecasts, 2025-2035
  - 8.4.1.2. Application breakdown size & forecasts, 2025-2035
- 8.4.2. Germany AI in Biotechnology Market
  - 8.4.2.1. Offering breakdown size & forecasts, 2025-2035
  - 8.4.2.2. Application breakdown size & forecasts, 2025-2035
- 8.4.3. France AI in Biotechnology Market
  - 8.4.3.1. Offering breakdown size & forecasts, 2025-2035
  - 8.4.3.2. Application breakdown size & forecasts, 2025-2035
- 8.4.4. Spain AI in Biotechnology Market
  - 8.4.4.1. Offering breakdown size & forecasts, 2025-2035
  - 8.4.4.2. Application breakdown size & forecasts, 2025-2035
- 8.4.5. Italy AI in Biotechnology Market
  - 8.4.5.1. Offering breakdown size & forecasts, 2025-2035
  - 8.4.5.2. Application breakdown size & forecasts, 2025-2035
- 8.4.6. Rest of Europe AI in Biotechnology Market
  - 8.4.6.1. Offering breakdown size & forecasts, 2025-2035
  - 8.4.6.2. Application breakdown size & forecasts, 2025-2035
8.5. Asia Pacific AI in Biotechnology Market
- 8.5.1. China AI in Biotechnology Market
  - 8.5.1.1. Offering breakdown size & forecasts, 2025-2035
  - 8.5.1.2. Application breakdown size & forecasts, 2025-2035
- 8.5.2. India AI in Biotechnology Market
  - 8.5.2.1. Offering breakdown size & forecasts, 2025-2035
  - 8.5.2.2. Application breakdown size & forecasts, 2025-2035
- 8.5.3. Japan AI in Biotechnology Market
  - 8.5.3.1. Offering breakdown size & forecasts, 2025-2035
  - 8.5.3.2. Application breakdown size & forecasts, 2025-2035
- 8.5.4. Australia AI in Biotechnology Market
  - 8.5.4.1. Offering breakdown size & forecasts, 2025-2035
  - 8.5.4.2. Application breakdown size & forecasts, 2025-2035
- 8.5.5. South Korea AI in Biotechnology Market
  - 8.5.5.1. Offering breakdown size & forecasts, 2025-2035
  - 8.5.5.2. Application breakdown size & forecasts, 2025-2035
- 8.5.6. Rest of Asia Pacific AI in Biotechnology Market
  - 8.5.6.1. Offering breakdown size & forecasts, 2025-2035
  - 8.5.6.2. Application breakdown size & forecasts, 2025-2035
8.6. Latin America AI in Biotechnology Market
- 8.6.1. Brazil AI in Biotechnology Market
  - 8.6.1.1. Offering breakdown size & forecasts, 2025-2035
  - 8.6.1.2. Application breakdown size & forecasts, 2025-2035
- 8.6.2. Mexico AI in Biotechnology Market
  - 8.6.2.1. Offering breakdown size & forecasts, 2025-2035
  - 8.6.2.2. Application breakdown size & forecasts, 2025-2035
8.7. Middle East & Africa AI in Biotechnology Market
- 8.7.1. UAE AI in Biotechnology Market
  - 8.7.1.1. Offering breakdown size & forecasts, 2025-2035
  - 8.7.1.2. Application breakdown size & forecasts, 2025-2035
- 8.7.2. Saudi Arabia AI in Biotechnology Market
  - 8.7.2.1. Offering breakdown size & forecasts, 2025-2035
  - 8.7.2.2. Application breakdown size & forecasts, 2025-2035
- 8.7.3. South Africa AI in Biotechnology Market
  - 8.7.3.1. Offering breakdown size & forecasts, 2025-2035
  - 8.7.3.2. Application breakdown size & forecasts, 2025-2035
- 8.7.4. Rest of Middle East & Africa AI in Biotechnology Market
  - 8.7.4.1. Offering breakdown size & forecasts, 2025-2035
  - 8.7.4.2. Application breakdown size & forecasts, 2025-2035

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. IBM Corporation
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Financial Performance (Subject to Data Availability)
- 9.2.5. Product/Services Portfolio
- 9.2.6. Recent Development
- 9.2.7. Market Strategies
- 9.2.8. SWOT Analysis
9.3. Google DeepMind
9.4. NVIDIA Corporation
9.5. Intel Corporation
9.6. Biogen Inc.
9.7. Halliburton Company
9.8. Schlumberger Limited
9.9. BASF SE
9.10. Baker Hughes Company
9.11. Chevron Phillips Chemical Company
9.12. Croda International Plc.
9.13. Impact Fluid Solutions
9.14. M&D Industries of Louisiana, Inc.
9.15. Aubin Group
9.16. Trican Well Service Ltd.